The global remote patient monitoring (RPM) market is estimated to be valued at $40 Billion in 2023, and is expected to grow ...

This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

Detailed price information for Senseonics Holdings (SENS-A) from The Globe and Mail including charting and trades.

The U.S. Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check their phone ...

Complications caused by type 1 diabetes can be spotted years before they develop thanks to data from continuous glucose monitors, new evidence has suggested. Researchers from the University of ...

Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...

Germantown, Maryland Monday, February 10, 2025, 16:00 Hrs [IST] ...

Adena Health and DASCO Home Medical Equipment will collaborate to provide respiratory equipment, walkers, wheelchairs and ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

We are home to the world-renowned CONTOUR® portfolio of blood glucose monitoring systems and the exclusive global distribution partner for the Eversense® Continuous Glucose Monitoring Systems ...

implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced it has filed for CE Mark registration for the Eversense ® 365 CGM system. Eversense 365 is the ...